PT3168214T - 2-tioxo-imidazolidin-4-onas substituídas e seus análogos espiro, ingrediente anti-cancro ativo, composição farmacêutica, preparação medicinal, método para tratar cancro da próstata - Google Patents
2-tioxo-imidazolidin-4-onas substituídas e seus análogos espiro, ingrediente anti-cancro ativo, composição farmacêutica, preparação medicinal, método para tratar cancro da próstataInfo
- Publication number
- PT3168214T PT3168214T PT15818878T PT15818878T PT3168214T PT 3168214 T PT3168214 T PT 3168214T PT 15818878 T PT15818878 T PT 15818878T PT 15818878 T PT15818878 T PT 15818878T PT 3168214 T PT3168214 T PT 3168214T
- Authority
- PT
- Portugal
- Prior art keywords
- cancer
- imidazolidin
- thioxo
- ones
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/16—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C229/60—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Furan Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2014127705/04A RU2557235C1 (ru) | 2014-07-08 | 2014-07-08 | Замещенные 2-тиоксо-имидазолидин-4-оны и их спироаналоги, противораковый активный компонент, фармацевтическая композиция, лекарственный препарат, способ лечения рака простаты |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3168214T true PT3168214T (pt) | 2019-07-25 |
Family
ID=53611746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT15818878T PT3168214T (pt) | 2014-07-08 | 2015-06-26 | 2-tioxo-imidazolidin-4-onas substituídas e seus análogos espiro, ingrediente anti-cancro ativo, composição farmacêutica, preparação medicinal, método para tratar cancro da próstata |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US10450278B2 (pt) |
| EP (1) | EP3168214B1 (pt) |
| JP (1) | JP6581193B2 (pt) |
| KR (1) | KR102171120B1 (pt) |
| AU (1) | AU2015288381B2 (pt) |
| CA (1) | CA2954401C (pt) |
| CY (1) | CY1122231T1 (pt) |
| DK (1) | DK3168214T3 (pt) |
| ES (1) | ES2736507T3 (pt) |
| GE (1) | GEP20207096B (pt) |
| HR (1) | HRP20191265T8 (pt) |
| HU (1) | HUE044317T2 (pt) |
| LT (1) | LT3168214T (pt) |
| PL (1) | PL3168214T3 (pt) |
| PT (1) | PT3168214T (pt) |
| RS (1) | RS59009B1 (pt) |
| RU (1) | RU2557235C1 (pt) |
| SI (1) | SI3168214T1 (pt) |
| TR (1) | TR201910220T4 (pt) |
| UA (1) | UA117626C2 (pt) |
| WO (1) | WO2016007046A1 (pt) |
| ZA (1) | ZA201700922B (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018009678A1 (en) * | 2016-07-08 | 2018-01-11 | Janssen Pharmaceutica Nv | Substituted hydantoin and thiohydantoin derivatives as androgen receptor antagonists |
| CN107954936B (zh) * | 2016-10-17 | 2021-03-19 | 海创药业股份有限公司 | 一种制备氘代咪唑二酮类化合物的方法 |
| CN109422725A (zh) * | 2017-09-04 | 2019-03-05 | 北京美倍他药物研究有限公司 | 前列腺癌治疗药物 |
| RU2708253C2 (ru) * | 2017-12-05 | 2019-12-05 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Новые производные арил-тиогидантоина, ингибиторы андрогенового рецептора, способ получения и применения |
| MX2021007475A (es) | 2018-12-19 | 2021-08-05 | Celgene Corp | Compuestos de 3-((3-aminofenil)amino)piperidina-2,6-diona sustituida, composiciones de estos y metodos de tratamiento con estos. |
| CN113453681B (zh) | 2018-12-19 | 2024-10-11 | 细胞基因公司 | 经取代的3-((3-氨基苯基)氨基)哌啶-2，6-二酮化合物、其组合物及使用它们的治疗方法 |
| CN114621109B (zh) * | 2020-12-14 | 2024-04-26 | 成都苑东生物制药股份有限公司 | 一种阿帕他胺的合成方法及其中间体 |
| CN113698310B (zh) * | 2021-08-20 | 2023-03-17 | 江西金丰药业有限公司 | 一种恩杂鲁胺双酯中间体的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1893196B2 (en) * | 2005-05-13 | 2015-07-29 | The Regents of The University of California | Diarylhydantoin compound |
| SG173837A1 (en) * | 2009-02-24 | 2011-09-29 | Medivation Prostate Therapeutics Inc | Specific diarylhydantoin and diarylthiohydantoin compounds |
| DK3124481T3 (en) * | 2010-02-16 | 2018-05-07 | Aragon Pharmaceuticals Inc | ANDROGEN RECEPTOR MODULATORS AND APPLICATIONS THEREOF |
| DK2538785T3 (en) * | 2010-02-24 | 2018-05-22 | Medivation Prostate Therapeutics Llc | Methods for the synthesis of diarylthiohydantoin and diarylhydantoin compounds |
| RU2434851C1 (ru) * | 2010-07-22 | 2011-11-27 | Александр Васильевич Иващенко | Циклические n, n'-диарилтиомочевины или n, n'-диарилмочевины - антагонисты андрогенных рецепторов, противораковое средство, способ получения и применения |
| RU2520134C1 (ru) * | 2013-02-27 | 2014-06-20 | Общество с ограниченной ответственностью "Авионко" (ООО "Авионко") | Замещенные (r)-3-(4-метилкарбамоил-3-фторфениламино)-тетрагидро-фуран-3-енкарбоновые кислоты и их эфиры, способ их получения и применения |
-
2014
- 2014-07-08 RU RU2014127705/04A patent/RU2557235C1/ru active
-
2015
- 2015-06-26 US US15/324,658 patent/US10450278B2/en active Active
- 2015-06-26 RS RS20190891A patent/RS59009B1/sr unknown
- 2015-06-26 JP JP2017522315A patent/JP6581193B2/ja active Active
- 2015-06-26 EP EP15818878.9A patent/EP3168214B1/en active Active
- 2015-06-26 GE GEAP201514411A patent/GEP20207096B/en unknown
- 2015-06-26 PT PT15818878T patent/PT3168214T/pt unknown
- 2015-06-26 TR TR2019/10220T patent/TR201910220T4/tr unknown
- 2015-06-26 ES ES15818878T patent/ES2736507T3/es active Active
- 2015-06-26 DK DK15818878.9T patent/DK3168214T3/da active
- 2015-06-26 WO PCT/RU2015/000395 patent/WO2016007046A1/ru active Application Filing
- 2015-06-26 AU AU2015288381A patent/AU2015288381B2/en active Active
- 2015-06-26 UA UAA201700635A patent/UA117626C2/uk unknown
- 2015-06-26 HU HUE15818878 patent/HUE044317T2/hu unknown
- 2015-06-26 CA CA2954401A patent/CA2954401C/en not_active Expired - Fee Related
- 2015-06-26 LT LTEP15818878.9T patent/LT3168214T/lt unknown
- 2015-06-26 KR KR1020177003384A patent/KR102171120B1/ko active IP Right Grant
- 2015-06-26 PL PL15818878T patent/PL3168214T3/pl unknown
- 2015-06-26 SI SI201530801T patent/SI3168214T1/sl unknown
-
2017
- 2017-02-06 ZA ZA2017/00922A patent/ZA201700922B/en unknown
-
2019
- 2019-07-15 CY CY20191100752T patent/CY1122231T1/el unknown
- 2019-07-16 HR HRP20191265T patent/HRP20191265T8/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20191265T1 (hr) | 2019-10-18 |
| CA2954401A1 (en) | 2016-01-14 |
| KR102171120B1 (ko) | 2020-10-29 |
| EP3168214A4 (en) | 2018-02-14 |
| EP3168214A1 (en) | 2017-05-17 |
| US20180179164A1 (en) | 2018-06-28 |
| UA117626C2 (uk) | 2018-08-27 |
| DK3168214T3 (da) | 2019-07-22 |
| JP6581193B2 (ja) | 2019-09-25 |
| RS59009B1 (sr) | 2019-08-30 |
| CA2954401C (en) | 2021-03-02 |
| SI3168214T1 (sl) | 2019-09-30 |
| WO2016007046A1 (ru) | 2016-01-14 |
| JP2017522379A (ja) | 2017-08-10 |
| HRP20191265T8 (hr) | 2019-11-01 |
| RU2557235C1 (ru) | 2015-07-20 |
| CY1122231T1 (el) | 2020-11-25 |
| PL3168214T3 (pl) | 2019-10-31 |
| LT3168214T (lt) | 2019-07-25 |
| GEP20207096B (en) | 2020-04-10 |
| TR201910220T4 (tr) | 2019-07-22 |
| ES2736507T3 (es) | 2020-01-02 |
| EP3168214B1 (en) | 2019-04-24 |
| AU2015288381B2 (en) | 2019-11-07 |
| HUE044317T2 (hu) | 2019-10-28 |
| KR20170023184A (ko) | 2017-03-02 |
| AU2015288381A1 (en) | 2017-03-02 |
| ZA201700922B (en) | 2019-08-28 |
| US10450278B2 (en) | 2019-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20191265T8 (hr) | Supstituirani 2-tiokso-imidazolidin-4-oni i njihovi spiro analozi, aktivni anti-kancerogeni sastojak, farmaceutska kompozicija, medicinski preparat, metoda za liječenje raka prostate | |
| EP3263135A4 (en) | Pharmaceutical composition for treating cancer comprising microrna as active ingredient | |
| HUE049341T2 (hu) | Szubsztituált indazolok, eljárás ezek elõállítására, ezeket tartalmazó gyógyszerkészítmények, valamint ezek alkalmazása gyógyszerkészítmények elõállítására | |
| GB201411465D0 (en) | Active pharmaceutical ingredient (api) comprising cannabinoids for use in the treatment of cancer | |
| HK1251464A1 (zh) | 含有陰離子藥物的藥物組合物及其製備方法 | |
| HK1254643A1 (zh) | 用於藥品給藥和混合及其恰當技術訓練的裝置和方法 | |
| SG11201605868XA (en) | Pharmaceutical composition for cancer treatment and pharmaceutical preparation for cancer treatment containing same composition as active ingredient | |
| EP3560518A4 (en) | COMPLEX FOR ADMINISTRATION AND STABILIZATION OF MEDICINAL PRODUCTS AND METHOD FOR MANUFACTURING THEREOF | |
| HK1217303A1 (zh) | 種治療白血病的藥物組合物及其製備方法 | |
| SG11201610636VA (en) | Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor | |
| EP3202417A4 (en) | Vaccine pharmaceutical composition for transdermal administration | |
| HK1223630A1 (zh) | 抗- 療法的實施與用量 | |
| EP3295949A4 (en) | Topical drug for treating breast cancer and preparation method thereof | |
| EP3100744A4 (en) | Composition for accelerating penetration through skin, preparation for transdermal administration, and skin patch preparation | |
| GB201621559D0 (en) | A method for the preparation of a delivery drug delivery system and a composition therefor | |
| IL249860A0 (en) | Pharmaceutical preparations, methods for their preparation and their use for the treatment of cancer | |
| EP3100743A4 (en) | Composition for accelerating penetration through skin, preparation for transdermal administration, and skin patch preparation | |
| HK1214770A1 (zh) | 清痹中藥組合物及其製備方法 | |
| GB201414271D0 (en) | Composition for delivery of an active pharmaceutical substance and method of preparing same |